Vitamin-One Formulas Ltd.
6 known investors
Vitamin Lab produces personalized vitamin and supplement formulas customized to individual health goals, lifestyle, and nutritional needs. The company uses evidence-based research and allows customers to adjust their formulas dynamically over time.
Also known as Vitamin-One Formulas Ltd. Β· VitaminLab
Investors Β· 6
Also in the syndicate Β· 2
Company profile
researched Aug 2026Vitamin-One Formulas Ltd., trading as VitaminLab, is a Vancouver, British Columbia-based personalized nutrition company that formulates individualized vitamin and supplement products. Customers complete a health questionnaire covering lifestyle, family and medical history, current medications and health goals, or build a formula directly, and receive a single custom powder or capsule blend containing vitamins, minerals, fish oil, herbs, nutraceuticals and adaptogens at ingredient- and dose-specific levels. Formulas are designed to be revised over time β customers can update ingredients every three months in response to changed goals, seasons, sensitivities or budget.
The company describes an evidence-based formulation process run by a team of integrated medical doctors, naturopaths, nutritionists and pharmacists, drawing on peer-reviewed clinical trial literature and nutraceutical databases while also considering traditional ingredient use. Its coverage extends to a nutrient list of more than 200 ingredients, and formulation and production use a patented process and equipment. Products are made at an NSF GMP registered facility without artificial fillers or binders, with third-party and in-house testing. Because of regulations governing custom formulas, the company cannot ship to all locations; visitors in restricted regions can complete the quiz but not place an order. The site also references an "Upload a Test" feature governed by a separate privacy policy, indicating use of test results as an input to formulation.
Business model
VitaminLab sells personalized supplement formulas produced to individual specification, with formulas intended to be updated periodically, supporting a recurring purchase relationship. The health questionnaire and resulting formula recommendation and product quote are provided free of charge, with no obligation to buy.
Revenue comes from sales of custom-formulated supplements ordered through the website, positioned as consolidating multiple separately purchased over-the-counter supplements into one blend.
Traction
The company's site cites over 10,000 satisfied customers using dynamic formulas. Press coverage of the Series A described significant growth across practitioner, direct-to-consumer and testing-partner channels. As of the site snapshot, a new version of the health quiz was still in development, with an email waitlist in place.
Latest developments
Series A financing co-led by Nimbus Synergies and DSM Venturing was reported in January 2024 to fund technology investment, facility and automated line development, and expansion of sales and marketing including into the practitioner channel. The company's website indicates a revised health quiz is being finalized by its pharmacist and nutritionist team.
βΈFull profile β market position, technology, go-to-market, geography, history, risks & controversies
Market position
The company operates in the personalized nutrition and VMS category, where other personalized vitamin providers have included Care/of, and where large consumer-health and private-equity acquirers are active. Investors described VitaminLab as capital efficient to date.
VitaminLab emphasizes fully custom, dose-specific single-formula products that can be reformulated over time, versus fixed multivitamins or pre-packaged multi-pill packs, alongside practitioner involvement in formulation and a claimed patented production process.
Technology
Formulation draws on multiple individual data points, including DNA, health history and blood test results, combined with an evidence-based methodology referencing current trials and nutraceutical databases. Manufacturing uses a patented process and equipment, with investment directed at automated production lines.
Go-to-market
Distribution spans direct-to-consumer online sales, integrated healthcare practitioners, and partnerships with health testing companies. Proceeds of the Series A were designated for scaling go-to-market operations in North America and expanding sales and marketing into the practitioner market.
Consumers seeking supplement regimens tailored to specific health goals such as immunity, energy and stress or adrenal support, as well as healthcare practitioners who recommend formulas to patients.
Geography
Headquartered and legally domiciled at 1055 West Hastings Street, Suite 1700, Vancouver, British Columbia, Canada, with personal data processed in the United States, Canada or other countries where the company or its agents maintain facilities. Go-to-market scaling is focused on North America, and shipping is unavailable in some jurisdictions due to custom-formula regulations.
History
The legal entity Vitamin-One Formulas Ltd. was created on 2015-10-21 in British Columbia (registry number BC1052715). Under CEO Anton Solonnikov, the company raised a Series A round co-led by Nimbus Synergies and DSM Venturing, reported in January 2024, to fund technology, facilities, automated production lines and commercial expansion. An LEI (254900DNNNTBP8IM5E54) was issued on 2025-01-22 and lapsed as of 2026-01-23.
Risks & controversies
Regulatory restrictions on custom formulas prevent shipping to certain locations, limiting addressable geography. The company's LEI registration has lapsed and is flagged non-conforming, though the underlying BC corporate registration remains active. The personalized vitamin segment has seen failures, including Care/of ceasing operations after losing funding.
Compiled by commissioned research from 8 cited public sources β announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed β not independently audited.
Timeline Β· 4
launches, deals, and filingsThe company's LEI registration status changed from ISSUED to LAPSED and is flagged as non-conforming with ROC policy; the underlying BC corporate registry status remains ACTIVE.
LEI 254900DNNNTBP8IM5E54 issued to Vitamin-One Formulas Ltd. by Bloomberg Finance L.P., fully corroborated against BC Registry Services.
Nimbus Synergies and DSM Venturing co-led a Series A investment in Vitamin-One Formulas Ltd. (dba VitaminLab), with proceeds earmarked for scaling North American go-to-market operations, facilities and automated production lines, and expansion into the practitioner market.
Entity creation date recorded in BC Registry Services / GLEIF records under registry number BC1052715.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
βΈResearch sources Β· 8
primary sources listed
- Vitamin-One Formulas Ltd.getvitaminlab.com Β· web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Vitamin-One Formulas Ltd. do?
- VitaminLab makes custom-formulated vitamin and supplement blends built to each customer's health goals and lifestyle.
- Who are Vitamin-One Formulas Ltd.'s investors?
- Vitamin-One Formulas Ltd.'s investors include Angel Forum, Relentless Pursuit Partners, Sproutx, WUTIF Capital.